Page 204 Acute Pain Management
P. 204

 




Large
IV
bolus
doses
of
tramadol
can
result
in
a
high
incidence
of
emetic
symptoms.
This
effect

can
be
reduced
by
slowing
delivery
of
the
drug
or,
in
the
surgical
setting,
by
giving
it
before

the
patient
emerges
from
general
anaesthesia
(Pang
et
al,
2000
Level
II).


Continuous infusions
A
continuous
infusion
of
opioids
results
in
constant
blood
levels
after
approximately
4
half‐
lives
of
the
opioid
used.
The
aim
of
an
infusion
is
to
avoid
the
problems
associated
with
the

peaks
and
troughs
of
intermittent
administration
techniques.
However,
the
variation
in
patient

response,
the
changing
intensity
of
acute
pain
with
time
and
the
delay
between
any
alteration

of
the
infusion
rate
and
its
subsequent
effect,
may
result
in
inadequate
treatment
of
incident

pain
or
delayed
onset
of
side
effects,
such
as
respiratory
depression.
Very
close
monitoring
is

therefore
essential
with
continuous
infusions
of
opioids.

Compared
with
PCA,
continuous
IV
opioid
infusions
in
a
general
ward
setting
resulted
in
a

5‐fold
increase
in
the
incidence
of
respiratory
depression
(Schug
&
Torrie,
1993
Level
IV).


6.2.2 Non-selective non-steroidal anti-inflammatory drugs
and coxibs
There
are
only
a
limited
number
of
nsNSAIDs
or
coxibs
available
for
IV
injection
at
present
and

fewer
still
where
Level
I
evidence
for
individual
efficacy
is
available.
In
single
doses
as
the
sole

analgesic
agent,
the
coxib
parecoxib
IV
20
to
40
mg
has
been
shown
to
be
effective
(Lloyd
et
al,

2009
Level
I).


The
formulation
of
drug
used
may
affect
efficacy.
Comparison
of
a
polyethylene
glycol
and

benzyl
alcohol
(PG‐BA)
diclofenac
solution
with
one
that
used
hydroxypropyl
beta‐cyclodextrin

CHAPTER
6
 more
rapid
onset
of
analgesia
(Leeson
et
al,
2007
Level
II).
The
incidence
of
moderate
to
severe,

(HPβCD)
to
solubilise
diclofenac
in
a
small
volume
showed
that
IV
HPβCD
diclofenac
resulted
in


but
not
mild
thrombophlebitis
may
be
less
with
IV
diclofenac
(Colucci
et
al,
2009).


In
most
cases
the
route
of
administration
does
not
seem
to
alter
efficacy.
IV
nsNSAIDs
or

coxibs
are
more
expensive
than
oral
or
rectal
nsNSAIDs
although
their
efficacy
and
likelihood

of
side
effects
is
similar
(Tramer
et
al,
1998
Level
I).
A
more
recent
comparison
of
rectal

diclofenac
and
IV
parecoxib
showed
no
difference
in
pain
relief,
side
effects
or
rescue

analgesic
requirements
(Ng
et
al,
2008
Level
II).
Efficacy
and
times
to
onset
of
analgesia
were

similar
with
IV
and
IM
parecoxib
(Daniels
et
al,
2001
Level
II).

For
renal
colic,
the
onset
of
action
of
NSAIDs
was
faster
when
given
IV
compared
with
IM,
oral

or
rectal
administration
(Tramer
et
al,
1998
Level
I).



6.2.3 Paracetamol
IV
paracetamol
was
an
effective
analgesic
after
surgery
(Sinatra
et
al,
2005
Level
II).
It
was
of

faster
onset
than
the
same
dose
given
orally
(Moller,
Sindet‐Pedersen
et
al,
2005
Level
II)
but,
as

with
IV
NSAIDs,
it
is
more
expensive.


While
of
equal
analgesic
efficacy,
the
incidence
of
local
pain
at
the
infusion
site
was

significantly
less
after
IV
paracetamol
compared
with
the
prodrug
propacetamol
(Moller,
Juhl
et

al,
2005
Level
II).


Due
to
the
good
bioavailability
and
tolerability
of
oral
paracetamol,
the
use
of
the
IV
form

should
be
limited
to
clinical
circumstances
where
use
of
the
enteral
route
is
not
appropriate.








156
 Acute
Pain
Management:
Scientific
Evidence

   199   200   201   202   203   204   205   206   207   208   209